HealthNews

Ghana, Kenya, Malawi to gain further access to malaria jab

International support worth US $160 million from 2022 to 2025 will be made available to the aforementioned countries, which piloted the jab in 2019

The World Health Organization and Gavi, the Vaccine Alliance, have invited developing countries like Ghana, Kenya and Malawi to apply for funding to access the RTS,S malaria vaccine.

International support worth US $160 million from 2022 to 2025 will be made available to the aforementioned countries, which piloted the jab in 2019.

Other countries which are affected by malaria can apply for the funding from September.

It is thought one child dies from malaria each minute in Africa.

The WHO recommended the widespread use of the RTS,S vaccine in October 2021, which has led to more countries expressing an interest in it.

But the jab only provides 30% protection.

To date, about 1.3 million children have received at least one of the required four doses of the vaccine since it was piloted in 2019.

However, the supply remains limited in the continent.

Africa needs at least 80 to 100 million doses annually, according to the WHO.

The manufacturer GSK says it can only produce about 15 million doses every year until 2028.

“Lives are at stake, every day,” said Dr Matshidiso Moeti from the WHO.

Asaase Radio 99.5 – tune in or log on to broadcasts online
99.5 in Accra, 101.5 in Bawku, 99.9 in Bimbilla, 100.3 in Cape Coast, 90.7 in Ho, 98.5 in Kumasi, 99.7 in Tamale, 89.5 in Tarkwa and 106.9 in Walewale
Join the conversation. Call: 020 000 9951 or 059 415 7777. Or WhatsApp: 020 000 0995.
#AsaaseRadio
#TheVoiceofOurLand

Source
BBC
Show More

Related Articles

Back to top button

Adblock Detected

ALLOW OUR ADS